Literature DB >> 2950342

Cerebral decortication reverses the effect of amphetamine on striatal D2 dopamine binding site density.

H A Robertson.   

Abstract

Unilateral ablation of the cerebral cortex produces a decrease of approximately 38% in striatal D2 dopamine binding site density. Chronic d-amphetamine treatment also produces a decrease of about 22% in D2 binding site density. Paradoxically, when rats were hemidecorticated and treated chronically with d-amphetamine, the density of striatal D2 dopamine binding sites on the decorticated side was increased (by about 50%) rather than decreased. Evidently d-amphetamine-induced down-regulation of D2 dopamine binding sites depends on an intact corticostriatal pathway.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2950342     DOI: 10.1016/0304-3940(86)90535-5

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  6 in total

1.  Knocking out the dopamine reuptake transporter (DAT) does not change the baseline brain arachidonic acid signal in the mouse.

Authors:  Epolia Ramadan; Lisa Chang; Mei Chen; Kaizong Ma; F Scott Hall; George R Uhl; Stanley I Rapoport; Mireille Basselin
Journal:  Int J Neurosci       Date:  2012-03-26       Impact factor: 2.292

2.  Concurrent choice for social interaction and amphetamine using conditioned place preference in rats: effects of age and housing condition.

Authors:  Justin R Yates; Joshua S Beckmann; Andrew C Meyer; Michael T Bardo
Journal:  Drug Alcohol Depend       Date:  2013-03-26       Impact factor: 4.492

3.  Dopamine D2 receptor alteration in patients with periodic movements in sleep (nocturnal myoclonus).

Authors:  J Staedt; G Stoppe; A Kögler; D Munz; H Riemann; D Emrich; E Rüther
Journal:  J Neural Transm Gen Sect       Date:  1993

4.  Chronic d-amphetamine depresses an imaging marker of arachidonic acid metabolism in rat brain.

Authors:  Abesh K Bhattacharjee; Lisa Chang; Mei Chen; Laura White; Jane M Bell; Richard P Bazinet; Stanley I Rapoport
Journal:  Int J Neuropsychopharmacol       Date:  2008-06-23       Impact factor: 5.176

5.  Single photon emission tomography (SPET) imaging of dopamine D2 receptors in the course of dopamine replacement therapy in patients with nocturnal myoclonus syndrome (NMS).

Authors:  J Staedt; G Stoppe; A Kögler; H Riemann; G Hajak; D L Munz; D Emrich; E Rüther
Journal:  J Neural Transm Gen Sect       Date:  1995

6.  Lamotrigine in the treatment of nocturnal myoclonus syndrome (NMS): two case reports.

Authors:  J Staedt; G Stoppe; H Riemann; G Hajak; E Rüther; P Riederer
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.